Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System.

The aim of this study was to validate quantitative performance of a newly released simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) scanner, by using MR-based attenuation correction (MRAC), both in phantom study and in patient study. PET/MRI image uniformities of a ph...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 11
Autores principales: Liu, Guobing, Cao, Tuoyu, Hu, Lingzhi, Zheng, Jiaxu, Pang, Lifang, Hu, Pengcheng, Gu, Yushen, Shi, Hongcheng
Formato: diagnostic images pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 11/28/2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139934823&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139934823
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 11/28/2019
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        139934823
        139934823
        139934823
        10.1155/2019/8213215
        139934823
      ppf: 1
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System.
      aug:
        au:
          Liu, Guobing
          Cao, Tuoyu
          Hu, Lingzhi
          Zheng, Jiaxu
          Pang, Lifang
          Hu, Pengcheng
          Gu, Yushen
          Shi, Hongcheng
        affil: Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
      sug:
        subj:
          Tomography, Emission-Computed Methods
          Magnetic Resonance Imaging Methods
          Image Interpretation, Computer Assisted Methods
          Artifacts
          Phantoms, Imaging
          Sensitivity and Specificity
          Human
          Fludeoxyglucose F 18 Diagnostic Use
          Tomography, X-Ray Computed Methods
          Liver Radiography
          Lung Radiography
          Connective Tissue Diseases Radiography
          Bone Diseases Radiography
      ab: The aim of this study was to validate quantitative performance of a newly released simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) scanner, by using MR-based attenuation correction (MRAC), both in phantom study and in patient study. PET/MRI image uniformities of a phantom under different hardware configurations were tested and compared. Thirty patients were examined with 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) PET/computed tomography (CT) and subsequent PET/MRI. PET images from PET/MRI were corrected with MRAC (PETMR), CT-based attenuation maps (μ-maps, PETCT), and segmented CT μ-maps (PETCTSeg) derived from PET/CT. Standardized uptake values (SUVs) were compared among the 3 sets of PET in main organs (bone, liver and lung) and in 52 FDG-avid lesions, including soft-tissue lesions and bone lesions. The result showed that PET imaging uniformities of PET/MRI under different configurations were good (<8.8%). The SUV differences among the 3 sets of PET varied with organs and lesion types. In detail, the mean relative differences of SUV between PETMR and PETCT were as follows: −18.8%, bone (SUVmean); −8.0%, liver (SUVmean); −12.2%, lung (SUVmean); −18.1%, bone lesions (SUVmean); −13.3%, bone lesions (SUVmax); −8.2%, soft-tissue lesions (SUVmean); and −7.3%, soft-tissue lesions (SUVmax). The mean relative differences between PETMR and PETCTSeg were as follows: −19.0%, bone (SUVmean); −3.5%, liver (SUVmean); −3.3%, lung (SUVmean); −19.3%, bone lesions (SUVmean); −17.5%, bone lesions (SUVmax); −5.5%, soft-tissue lesions (SUVmean); and −4.4%, soft-tissue lesions (SUVmax). The differences of SUV between PETMR and PETCT were larger than those between PETMR and PETCTSeg, in both soft tissue and soft-tissue lesions (P<0.001), but not in bone or bone lesions. In conclusion, MRAC in the newly released PET/MR system is accurate in most tissues, with SUV deviations being generally less than 10%, compared to PET/CT. In bone, however, underestimations can be substantial, which may be partially attributed to segmentation of the MR-based μ-maps.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N